Skip to main content
. 2022 Jul 30;14(15):3146. doi: 10.3390/nu14153146

Table 2.

Summary of results in participants: key outcomes at 12 months.

Mean (SD)
n Baseline 12 Months Change 95% CI p Value
Weight (kg) 35 100.3 (16.8) 88.8 (14.3) 11.6 (8.9) 8.5–14.6 <0.001
BMI (kg/m2) 35 34.4 (4.5) 30.5 (4.2) 3.9 (2.8) 2.9–5.0 <0.001
Waist circumference (cm) 35 113.2 (11.5) 100.3 (10.8) 12.9 (8.9) 9.9–16.0 <0.001
Fat mass (%) 35 37.5 (8.8) 32.2 (9.6) 5.3 (4.9) 3.6–7.0 <0.001
Fat free mass (%) 35 62.5 (8.7) 67.8 (9.6) −5.3 (5.0) 3.6–7.0 <0.001
HbA1c (mmol/mol) 35 65.0 (20.6) 49.5 (17.1) 15.5 (19.5) 8.8–22.2 <0.001
HbA1c (%) 35 8.1 (1.9) 6.7 (1.6) 1.4 (1.8) 0.8–2.0 <0.001
Number of diabetes medications (mean, SD) 35 1.1 (0.8) 0.3 (0.7) 0.8 (0.6) 0.6–1.0 <0.001
Systolic blood pressure (mm Hg) 35 133.6 (14.9) 124.2 (10.6) 9.3 (16.2) 3.8–14.9 0.002
Diastolic blood pressure (mm Hg) 35 88.2 (9.7) 78.5 (12.0) 9.7 (14.6) 4.7–14.7 <0.001
Number of anti-hypertensive medications 35 0.9 (1.0) 0.6 (0.2) 0.3 (0.5) 0.5–3.5 0.001
Total cholesterol (mmol/l) 35 4.8 (1.5) 4.5 (1.3) 0.3 (1.1) −0.8–0.6 0.128
HDL cholesterol (mmol/l) 35 1.2 (0.4) 1.3 (0.4) 0.1 (0.2) −1.3–0.1 0.74
LDL cholesterol (mmol/l) 34 2.7 (1.1) 2.6 (0.8) 0.1 (0.8) −0.2–0.4 0.617
Triglycerides (mmol/l) 35 2.1 (2.2) 1.5 (1.8) 0.7 (0.9) 0.4–1.0 <0.001
Rosenberg 35 21.3 (5.2) 24.1 (5.0) −2.7 (3.9) −4.0–−1.4 <0.001
DDS Mean 35 2.3 (1.0) 1.8 (0.9) 0.5 (0.8) 0.2–0.7 0.001
PHQ9 35 5.3 (4.8) 3.4 (4.4) 1.9 (4.7) 0.3–3.5 0.021
GAD7 35 3.7 (4.4) 3.4 (4.7) 0.3 (3.7) −0.9–1.6 0.584
WAS 35 6.3 (6.7) 6.5 (9.5) −0.2 (8.2) −3.0–2.6 0.869
BES 35 9.3 (6.0) 7.7 (5.7) 1.5 (6.1) −0.6–3.6 0.144

Data are in n (%), mean (SD). %, percentage; n, number; BMI, body mass index, HbA1c, glycated haemoglobin; kg/m2, kilograms per metre squared, kg, kilograms; DDS = Diabetes Distress Score. PHQ9 = Patient Health Questionnaire. GAD7 = Generalised Anxiety Disorder Questionnaire. WAS = Work and Social Adjustment Scale. BES = Binge Eating Scale; mmol/L, millimoles per litre. HDL, high-density lipoproteins, LDL, low-density lipoproteins.